ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524715 announcements Sun Pharma. announcements and dividends declared BSE

Sun Pharma. Complete list of announcements declared & dividend announcements by Sun Pharma. 524715

Sun Pharma. 524715 listed on BSE and deals in

Announcements and dividends declared by Sun Pharma. 524715

Sun Pharma settles litigation with Incyte Corp
Sun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, leading to the dismissal of pending litigation in the US. Incyte has granted Sun a non-exclusive license for oral deu
Announcement as on 14 July 2025

Sun Pharma says working towards full regulatory resolution at 3 plants facing USFDA action
Sun Pharma focuses on compliance across its manufacturing units. It aims for full regulatory resolution at facilities facing USFDA action. The company has completed CAPA implementation at Halol. CAPA implementation is in process at Mohali and Dadra. R&
Announcement as on 08 July 2025

Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma
Kirti Ganorkar, a long-time Sun Pharma veteran, will take over as Managing Director from September 1, succeeding founder Dilip Shanghvi, who remains Executive Chairman. This transition marks the culmination of Sun Pharma's succession plan, as Ganorkar step
Announcement as on 14 June 2025

Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue development of the drug. Separately, a surpri
Announcement as on 04 June 2025

New launches to drive Sun Pharma’s future growth; PAT may take a hit by tax surge
Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit declined in the March quarter due to higher taxes. The
Announcement as on 02 June 2025

Announcements by Sun Pharma. first page | Next page | Prev page |

524715 Sun Pharma. current price & indicator signals

Moving Averages for Sun Pharma.

  • 5Day Average: 1760.44
  • 12Day Average: 1754.89
  • 20Day Average: 1776.67
  • 50Day Average: 1844.13
  • 100Day Average: 1868.71
  • 150Day Average: 1837.38
  • 200Day Average: 1806.58

524715 Indicators & signals

Indicator MACD (12,26,9)

1765.92, 1791.59, -30.89
Indicator MACD is in negative zone

Indicator ADX (14)

11.8, 22.58, 17.82
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524715 Sun Pharma. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 1778.25 1762.95 to 1854.80 0.87% 2.17 times
29 Thu Oct 2026 1762.95 1753.50 to 1771.60 0.28% 0.98 times
28 Wed Oct 2026 1758.00 1725.65 to 1762.50 -0.11% 0.25 times
27 Tue Oct 2026 1760.00 1742.95 to 1767.65 0.98% 0.21 times
26 Mon Oct 2026 1743.00 1730.00 to 1766.00 0% 2.77 times
23 Fri Oct 2026 1743.00 1735.65 to 1768.55 -0.62% 0.28 times
22 Thu Oct 2026 1753.95 1720.00 to 1754.90 0.51% 1.26 times
21 Wed Oct 2026 1745.00 1721.70 to 1755.60 0% 2.9 times
19 Mon Oct 2026 1745.00 1735.70 to 1768.95 -0.85% 0.35 times
16 Fri Oct 2026 1760.00 1744.85 to 1764.40 -0.03% 0.32 times
15 Thu Oct 2026 1760.60 1730.00 to 1777.40 0.67% 0.69 times
14 Wed Oct 2026 1748.90 1725.70 to 1777.05 -1.14% 0.47 times

Videos related to: 524715 announcements Sun Pharma. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524715 announcements Sun Pharma. announcements and dividends declared BSE

 

Back to top